Advanced Heart Failure Cardiologist

Legacy Health•Portland, OR

2d•Hybrid

About The Position

Legacy Medical Group (LMG), a physician-led health system in the greater Portland, Oregon metropolitan area, is seeking a dynamic, forward-thinking BC/BE Advanced Heart Failure and Transplant Cardiologist to lead and expand our community-based Advanced Heart Failure Program. This physician will spearhead programmatic development, clinical operations, and cardiogenic shock care across our multi-hospital network, working collaboratively with interventional cardiology, cardiothoracic surgery, critical care, and regional academic partners.

Requirements

MD or DO from an accredited medical school.
Completed ACGME-accredited Internal Medicine Residency, Cardiovascular Disease Fellowship, and an accredited Advanced Heart Failure & Transplant Cardiology Fellowship.
Board Certified/Eligible in Cardiovascular Disease and Advanced Heart Failure & Transplant Cardiology.
Documented procedural competence in right heart catheterization, endomyocardial biopsy (preferred), and temporary MCS/ECMO management.
Unrestricted Oregon medical license (or eligible to obtain) and valid ACLS certification.
Unable to sponsor H-1B or J-1 visa waivers at this time.

Nice To Haves

endomyocardial biopsy

Responsibilities

Serve as the clinical and operational leader for heart failure care across the system, establishing standardized GDMT protocols, transition-of-care pathways, and outpatient GDMT optimization clinics.
Provide leadership for an active, multidisciplinary 24/7 Shock Team, utilizing standardized invasive hemodynamic assessment and rapid escalation protocols.
Direct clinical management of temporary and durable MCS, including percutaneous ventricular assist devices (Impella CP/5.5, ProtekDuo, intra-aortic balloon pumps), veno-arterial (VA) ECMO, and acute-on-chronic decompensated heart failure.
Oversee ambulatory hemodynamic monitoring (CardioMEMS), Barostim and Cardiac Contractility Modulation (CCM).
Foster direct clinical relationships and bridge-to-transplant/bridge-to-durable LVAD referral algorithms with local transplant programs, with potential opportunities for shared clinical conferences, joint committees, and cross-institutional collaboration.